ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 224

Silent Monosodium Urate Crystals Deposits in Asymptomatic Hyperuricemia Lead to a Higher Need for Coronary Revascularization

Mariano Andrés1, María Amparo Quintanilla2, Francisca Sivera3, José Sánchez-Payá4, Juan M Ruiz-Nodar5, Eliseo Pascual1,6 and Paloma Vela1,6, 1Sección de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain, 2Sección de Cardiología, Hospital General Universitario de Elda, Alicante, Spain, 3Reumatología, Hospital General Universitario de Elda, Alicante, Spain, 4Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Alicante, Spain, 5Servicio de Cardiología, Hospital General Universitario de Alicante, Alicante, Spain, 6Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, Crystal-induced arthritis, hyperuricemia and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Increased cardiovascular (CV) risk in gout relates to crystal-driven inflammation. In a preliminary, cross-sectional study we found that silent deposits of monosodium urate (MSU) crystals in asymptomatic hyperuricemia (AH) associated with a more severe coronary calcification, in comparison to AH alone and normouricemia (NU) [1]. Whether this silent deposit also leads to a poor CV prognosis of AH patients has not been assessed so far. We aimed to compare the incidence of CV events between the study groups in the follow-up period after the admission.

Methods:

Prospective follow up of patients from the previous study [1]; consecutive patients admitted due to an acute coronary event  were classified at baseline as NU, AH alone, and AH with crystals after serum uric acid levels, joint ultrasound and polarized microscopy of synovial fluid samples. The date of admission was considered as the index date. Electronic clinical records were reviewed in order to register the occurrence of all-cause death, CV-related death, new ST-elevation (STE) acute coronary event, new non-STE acute coronary event, and need for coronary revascularization during follow-up. Kaplan-Meier curves were plotted for each outcome for between-group comparisons, and a multivariate Cox regression model was built to adjust for CV risk factors.

Results:

140 patients were enrolled, and classified as 66 NU, 61 AH alone, and 13 AH with MSU crystals. Only one patient (from the AH alone group) was lost in the follow-up. Median (p25-75) follow-up was 12.0 (8.3-16.0) months. No new STE acute coronary event was registered. No significant differences were found in all-cause or CV-related death. The AH with crystals group showed higher need for new coronary revascularization and higher incidence of new non-STE acute coronary event [Figures A and B, respectively). After adjustment for CV risk factors, a non-sigficant but evident trend towards a higher need for new coronary revascularization was found in the AH with crystals group (aHR 4.5; 95%CI 0.8-24.1, p=0.08); no significant differences in non-STE acute event were found.

Conclusion:

Silent deposits of MSU crystals in AH appear to lead to a higher need for new coronary revascularization. Low patient numbers likely account for the lack of significance. This finding adds more evidence to the detrimental role of MSU crystals on the arteriosclerotic disease of these subjects.

References:

[1] 2014 ACR Annual Meeting (abstract #829).

Figure:


Disclosure: M. Andrés, None; M. A. Quintanilla, None; F. Sivera, None; J. Sánchez-Payá, None; J. M. Ruiz-Nodar, None; E. Pascual, Menarini, 5; P. Vela, None.

To cite this abstract in AMA style:

Andrés M, Quintanilla MA, Sivera F, Sánchez-Payá J, Ruiz-Nodar JM, Pascual E, Vela P. Silent Monosodium Urate Crystals Deposits in Asymptomatic Hyperuricemia Lead to a Higher Need for Coronary Revascularization [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/silent-monosodium-urate-crystals-deposits-in-asymptomatic-hyperuricemia-lead-to-a-higher-need-for-coronary-revascularization/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/silent-monosodium-urate-crystals-deposits-in-asymptomatic-hyperuricemia-lead-to-a-higher-need-for-coronary-revascularization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology